A panel of the Pennsylvania Supreme Court ruled that “There was sufficient evidence of gross negligence and willful and wanton misconduct to support imposition of punitive damages,” against Pfizer and units Wyeth and Pharmacia & Upjohn. As a result, Pfizer must pay more than $45 million in damages to Connie Barton and Donna Kendall.  The court noted that while the amount of punitive damages was large, it “correlated with the enormity of the defendants’ wrongs,

Pfizer and its Wyeth and Pharmacia & Upjohn units have resolved about 46 percent of suits that claimed the companies’ hormone-replacement medicines, including Prempro, Prempro and Provera, caused breast cancer, according to the Securities and Exchange Commission filing. Pfizer said it added $68 million to the $772 million it already reserved for the cases according to Bloomberg. The latest revelation comes after a $72.6 million dollar jury verdict against Pfizer and its units Wyeth and

In a closely watched trial in Philadelphia, a jury has awarded three women $ 72.6 million for developing breast cancer after using menopausal drugs made by Pfizer’s units Wyeth and Pharmacia Upjohn this according to Bloomberg. Plaintiff Judy Mulderig used Premarin and Provera for more than 11 years and was awarded $24.75. Plaintiff Bernadette Kalenkoski used Prempro for 4 years and was awarded $27.85 million while Susan Elfont was awarded $20 million. It is estimated

Bloomberg reports that Pfizer has won another lawsuit involving Prempro.  The federal jury in West Virginia ruled that Leah Royce Hines’ breast cancer was not caused by her use of the hormone drug – Prempro. Mrs. Hine’s lawyer, Harry F. Bell Jr. of The Bell Law Firm, said “the verdict is not surprising given the defense’s resources and how restricted the evidence in the case was.”  Mr. Bell went on to state: The defense’s resources

On July 8, 2011, Pfizer filed a pleading in the MDL Proceedings (4:03-cv-1507) asserting that there may be no reason for core discovery to take place in the MDL proceedings thereby permitting many cases to be remanded to the trial court for scheduling orders with trial dates.  This development may be significant for the thousands of cases in the MDL proceeding. Cases ripe for remand will involve those cases where only Wyeth/Upjohn are named as

Bloomberg reports that the United States Supreme Court has denied Pfizer’s appeal of a $58 million dollar jury verdict awarded to three women in 2007.  This means that the damage award stands as well as the award of more than $1.6 million in attorney fees. The initial jury verdict was $134 million but this sum was reduced by the trial judge to $58 million. For the approximately 10,000 women who have filed lawsuits against manufacture